Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques

Recruiting now · Phase 4

Conditions studied: Coronary Artery Disease

In brief

Effects of inclisiran + statins vs. statins on the morphology and vascular function of coronary vulnerable plaques, in order to provide a better treatment and more detailed imaging basis for the treatment of coronary vulnerable plaques.

Key facts

Study ID

NCT06338293

Run by

Nanjing First Hospital, Nanjing Medical University

People needed

40

Starts

2024-03-15

Expected to finish

2025-12-31

Last updated by the study team

2025-02-14

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• NanJing Frist Hospital — Nanjing, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.